Clinical outcomes of severe COVID-19 patients receiving early VV-ECMO and the impact of pre-ECMO ventilator use.
ARDS
COVID-19
awake ECMO
early ECMO
mechanical ventilation
mortality
observational
Journal
The International journal of artificial organs
ISSN: 1724-6040
Titre abrégé: Int J Artif Organs
Pays: United States
ID NLM: 7802649
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
pubmed:
8
10
2021
medline:
3
11
2021
entrez:
7
10
2021
Statut:
ppublish
Résumé
Acute respiratory distress syndrome (ARDS) in COVID-19 patients is associated with poor clinical outcomes and high mortality rates, despite the use of mechanical ventilation. Veno-Venous Extracorporeal membrane Oxygenation (VV-ECMO) in these patients is a viable salvage therapy. We describe clinical outcomes and survival rates in 52 COVID-19 patients with ARDS treated with early VV-ECMO at a large, high-volume center ECMO program. Outcomes included arterial blood gases, respiratory parameters, inflammatory markers, adverse events, and survival rates. Patients' mean age was 47.8 ± 12.1 years, 33% were female, and 75% were Hispanic. At the end of study period, 56% (
Identifiants
pubmed: 34615404
doi: 10.1177/03913988211047604
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM